Well if you are just gambling with your money by being in a microcap highly speculative biotech stock and don't care if it goes to zero then leave it in. You mentioned long term capital gains so I figured that meant you were looking to hold it for over a year. I believe their drug data is due out in 10 months. So if you are holding for over a year then the main event you are waiting on will have occurred and it's a pretty binary trade. Either you make a lot or you lose it all. All that said I don't know what the true upside of this stock is even with a viable drug.
robbie the bear strikes!!!! I told you tnxp was a killer at $5.98 1. my mom is a neurologist and she looked at this before i posted, neurologists deal with fibromyalgia, the reality is there is no comfortable way for people to sleep now with FM and this is just a reformulation of an existing drug.....so FDA approval is very simple and more than likely a done deal for 1 big reason the board of directors Ernest mario - former ceo of glaxo-smith kline samuel saks - former CEO of jazz the FDA is like politics....its all who you know.....these are some of the biggest guys in the game and samuel saks led JAZZ from a few pennies to $117 in a few years the drug work.......the government raised awareness of FM this year bc too many are going undiagnosed, and this drug isn't a miracle cure, its just an add on to existing meds and basically a narcotic to help you sleep well which you can't do if your whole body is in pain the initial test of 18 people went fantastic......the next test due in october is the big one bc once it pass phase 2 if it does, it will be sold for near $1B or 25x more than today.....MAPP was another one which recently passed phase 2 and was sold before FDA approval for $950M .......yes BEFORE FDA approval.....bc if they wait till after then its probably a $2-3B company look like i said.....when the downside is 50% with non approval and upside is 30-60x your money with approval......YOU MAKE THE TRADE jazz pharmaceuticals with xyrem is a $6.6B company today.......yes $6.6B with a drug for narcolepsy.....how big is the narcolepsy market???? miniscule at best but the drug is expensive and paid for by insurance 10M fibromyalgia sufferers......imagine all those want to be able to sleep well......even 5M of those at $6-8/day......and you have a $1B/year drug im super long TNXP and once again just like HIMX.....I was right...
the reason it popped over 30% twice this week and is up 100% in a month is bc it finally went over $5 with the reverse split and now hedge funds are buying......those guys don't buy under $5 and with a teeny tiny float, of which 76% is owned by insiders there aren't that many shares to purchase and/or short.....when the stock drops its bc of a selloff not shorts......short interest is under 1% I wouldn't bet against a $44m biotech with such bigshots on the board of directors serving Fibromyalgia and post traumatic stress disorder.....2 major problems in this country especially with all the soldiers in 10 months its probably $30 anyways before the trial results are announced and then you can take some off the table.....now its a screaming buy just remember when a stock moves like that.....someone probably knows something....
What is your thesis for owning it? What do you believe is the catalyst for it to move up and why? What is the potential downside and what would cause that? What do you view as the likelihood of each? If you can't answer these questions, you are basically gambling because you have no idea why you're in the stock or what you believe will happen - I think that's what robbie was referring to. If you can answer the questions, then those answers will tell you whether you should hold it or not.
keep an eye on IPCI, HALO, ERII IPCI is going to be a leader in generic drugs HALO is a leader in hyaluronidase delivery of existing drugs such as herceptin and insulin ERII a few pages back you can see what I wrote about them being a leader in increasing plant fluid efficiencies.
IF you wanna invest in TNXP watch this......my mom sent it to me, its the CEO speaking at a conference about what they're doing.....its 1 hour long, but you will see why I told you its going up at least 20 fold soon......the link i posted on the previous place explains more......but overall there's a reason its up 100% in the last week or so..... CEO of TNXP Conference Presentation
I like the prospect of this pharm company but that being said an lot of it is speculation here. you can just think of it as a one year call option. premium will be $0 at end of year or some multiple of whatever you paid for it. and the only thing you've done right so far is buy at a certain price and get a couple days right of positive price movement. this thing is fairly volatile. it would have to break $10 on momentum buying to see $14 in the near term. the volume hasn't been over 3.5million, the average either. it's just getting noticed now bc of that seeking alpha article. also the redraw split helped too. can revisit in 60 trading days to see where it's at
again.....why would the volume be so high, have you seen the float???? It's miniscule and again 76% is owned by insiders....again call it what you want, its obviously not exxon, but nobody got rich buying exxon at today's valuations. TNXP has a chance of being a 20-60 bagger just like many other pharmaceuticals if it gets approved....which it will, like I said my mother, a neurologist said its prospects are fantastic bc its a drug that's already in existence they're simply reformulating it ie it doesn't need the whole complex approval process.....if it passes next october its a done deal and then you're going to see it skyrocket but between now and then, no reason it can't hit $20 that would leave it at a $100M market cap $44M is too cheap, the CEO said it 3 days ago and it went up 30%, the reverse split and nasdaq listing recently helped shed light on this company its fine if you don't believe me but I feel my track record on here has been damn good starting with HIMX at $5.70 then IAG as a good trade at $4.50 before the debt ceiling crisis when it rose to $5.25 in a few weeks during that whole debacle just dont kick yourself if the drug is approved and you miss out on turning $5k into over $100k possibly $200k
Why Investing In Tonix Will Make You Rich Let me highlight the important part of why I told you it was nearly a slam dunk the other day before it ran up a quick 50%
no need to get over excited here with your post. we appreciate your enthusiastic inferences. your trade is merely a 10-20 bagger and to be frank I trade options and can hit a ten bagger on an options expiration Friday by investing far less money. all you've proven so far is that as a trade - it's been positive so far. bottom line nothing is guaranteed. as I said it's similar to a leap trade. you invest 1000 shares and it's either $0 or some multiple of what you put in a year later. the volume could be high for many reasons. people trading it. buy sell buy sell. have you watched level 2 all day for a week? why don't you take down what it's doing and report back. or we can look at the institutional sells or buys. I'm not saying it's a bad investment. all I'm saying is it's been a good trade so far.
TNXP - more importantly the cash position is $9million. burn rate seems to be about 9 a year too. this company is do or die come stage 3 approval because would have to get more financing to continue on. that being said a small investing of 1000 shares makes for a good trade for a year based mainly on speculation if what original poster claims will happen. question : what is pipeline for their other drugs?
SRPT took a nice chunk of mine too.. that was a weird morning waking up and seeing negative 60% they need to do a placebo controlled p3.. perhaps with glaxo and prosensas cooperation bc of the large number of participants required.. they already have a large base from their failed drisapersen trials. eteplirsen works. GSK's drisapersen doesn't (as well). the FDA, pressured or not by GSK's heavy pockets and lobbies, forced Sarepta into p3 trials. its really messed up bc you can see all the p2 boys had significant improvements. their 6 minute walking test data is great. now there is an unethical placebo control trial in the works. imagine you having a kid with duchenne dystrophy going into a clinical trial, but you dont even know if he will get a real dose. real cool FDA
this video is kinda made so it gets you emotionally and **** but its factual <iframe width="560" height="315" src="//www.youtube.com/embed/JPXLKpPNwrI" frameborder="0" allowfullscreen></iframe>
congrats on your options, but no need to downplay me. I bought TSLA calls recently, $141 or $142 for .04 and sold them for over $2 so I do fine in that field too.....too bad this has no options otherwise id buy calls also hit a 300% gain on some INTC dec $25 calls yesterday so no need to try to downplay what I'm saying I'm enthusiastic bc like I said, I've discussed this with a real live neurologist who happens to be good at her job and of course I call her mom and there aren't many times in life where you can get in on the ground floor of an opportunity like this. Like I said 3 days ago when I said we loaded up at $5.98 after I showed her the piece and she looked at the drugs involved, she said buy alot, that will easily get approved and of course we're up 50% in a few days The cash burn is irrelevant bc they have stated recently they have enough to finish phase 2b which is all they need to do and they're seeking a partner after that to buy them out ala MAPP, so TNXP will not be TNXP when its get approval it will be a drug in the basket of Lilly,Pfizer, etc.
bench moochie.....with a reformulation they are taking a drug approved 36 years ago by the FDA at doses 10x currently what they're seeking to use it for.....the approval is whether or not it actually reduces pain and the 36 people they just tested it on had a 26% improvement.....stage 2 now is for 4x the sample size....if that passes which based on what just happened it will then stage 3 is a shoe in and why they will get sold tons of drugs make it through stage 1, then 2, and flop at 3 bc there are so many varying side effects that can occur and longer term tests reveal that.....this is a drug that's already approved in smaller doses for a different disease....thats all.... again look at the board of directors.....First is the head of columbia university's department of medicine......then Ernest Mario who is 75 years old and probably worth of $100M as the ex glaxosmith kline ceo.....why would he bother? Why would Samuel Saks bother?? JAZZ just went from $.85 to $116 in the last 5 years, surely as the CEO he made some good money he could just relax in his mansion and not care.......they're involved bc they have the resources to push this though and they wanna be involved in a big project.....I doubt they wanna put their names on a flop again my mother said its all politics with the FDA and with a roster like that, its better off than 99% of other biotechs.......so TNXP it is
There's no real point in trying to converse with eddie. He doesn't actually have conversations. He just likes to hear himself talk and only talks about his winners.
